EVI5通过调节ERK1/2-c-Myc信号轴驱动肺腺癌的进展
Peipei Zhang1, Xinyang Zhang1, Tingting Cai1
1Department of Respiratory and Critical Care Medicine, The First People’s Hospital of Changzhou, Changzhou, China
Current cancer drug targets
|June 17, 2025
概括
生态热带病毒整合部位5 (EVI5) 通过激活ERK1/2-c-Myc通路,促进肺腺癌 (LUAD) 的进展. 这项研究揭示了EVI5作为LUAD潜在的治疗点,为其病变产生提供了新的见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肺腺癌 (LUAD) 是全球癌症死亡的主要原因.
- 生态热带病毒整合部位5 (EVI5) 参与瘤发生,但其在LUAD中的作用尚不清楚.
研究的目的:
- 研究EVI5在LUAD进展中的作用和潜在机制.
- 探索EVI5对LUAD细胞增殖,入侵和迁移的影响.
主要方法:
- 利用GEO和Kaplan-Meier数据库进行表达和预后分析.
- 产生了EVI5淘汰和过度表达的LUAD细胞系.
- 进行了扩散,入侵,迁移,西斑,免疫光和qRT-PCR测试.
主要成果:
- EVI5在LUAD中表达很高,并且与预后不佳有关.
- 过度表达EVI5增强了LUAD细胞的恶性行为;淘汰赛抑制了它们.
- 在LUAD进展中,EVI5激活了ERK1/2-c-Myc信号通路.
结论:
- EVI5通过ERK1/2-c-Myc信号轴促进LUAD恶性进展.
- EVI5代表了肺腺癌的潜在治疗标.
- 这项研究为LUAD病原体提供了新的见解.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K


